BIOCRYST PHARMACEUTICALS, INC. Property, Plant and Equipment, Gross
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Property, Plant and Equipment, Gross of $18.18 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-02-26
- 2025-12-31: Property, Plant and Equipment, Gross $18.18M.
- 2024-12-31: Property, Plant and Equipment, Gross $20.13M.
- 2023-12-31: Property, Plant and Equipment, Gross $19.12M.
- 2022-12-31: Property, Plant and Equipment, Gross $18.17M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2025-12-31 | $18.18M 10-K · filed 2026-02-26 |
| 2024-12-31 | $20.13M 10-K · filed 2026-02-26 |
| 2023-12-31 | $19.12M 10-K · filed 2025-02-25 |
| 2022-12-31 | $18.17M 10-K · filed 2024-02-27 |
| 2021-12-31 | $16.83M 10-K · filed 2023-02-27 |
| 2020-12-31 | $14.45M 10-K · filed 2022-02-28 |
| 2019-12-31 | $13.94M 10-K · filed 2021-03-01 |
| 2018-12-31 | $15.23M 10-K · filed 2020-03-13 |
| 2017-12-31 | $14.87M 10-K · filed 2019-03-14 |
| 2016-12-31 | $14.84M 10-K · filed 2018-03-12 |
| 2015-12-31 | $19.35M 10-K · filed 2017-02-27 |
| 2014-12-31 | $14.23M 10-K · filed 2016-02-26 |
| 2013-12-31 | $14.41M 10-K · filed 2015-03-02 |
| 2012-12-31 | $14.93M 10-K · filed 2014-03-10 |
| 2011-12-31 | $14.87M 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |